Evolutionary Tradeoffs in Antibiotic Resistance
抗生素耐药性的进化权衡
基本信息
- 批准号:10406982
- 负责人:
- 金额:$ 41.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:Antibiotic ResistanceAntibioticsAreaBacteriaBacteriophagesBiological ModelsClinicalComputer ModelsDataDatabasesDevelopmentEnvironmentEvolutionGenetic ModelsHorizontal Gene TransferHumanInfectionMiningModelingMutationPlasmidsPopulationPopulation GeneticsPrevalencePublic HealthResistanceRoleSelfish GenesStructureanthropogenesisemerging antibiotic resistanceexperimental studyfitnessindividual patientmicrobialmutantnovel therapeuticspathogenpressuresample fixation
项目摘要
Antibiotic resistance emerges when a mutation in a bacterium causes a previously inhibitory concentration of a
compound to become survivable. Through the accumulation of mutations conferring varying increases in
resistance, already many easy-to-treat infections have become nearly incurable, and are spreading in part
anthropogenically. The classical model of resistance evolution, that a resistant mutant has a fitness advantage in
the presence of antibiotic use, and so spreads in the population to near-fixation, captures the rise of antibiotic
resistance, but on closer inspection fails to explain several critical features of resistance. First, antibiotic
resistance rarely reaches fixation in clinical populations; more importantly, sensitivity is higher than the
population-genetic models would predict. Second, antibiotic resistance was present, and likely common, in
clinical infections before the human use of antibiotics even began. Third, despite the widespread prevalence of
antibiotic-producing bacteria in the environment, these same bacteria remain surrounded by sensitive
neighbors. For these reasons, we hypothesize that the existing model of resistance evolution is incomplete, and
in particular that there exist evolutionary factors in the environment which have a potentially countervailing
effect on resistance evolution of similar or greater magnitude to the human use of antibiotics. Here, we will
combine evolution experiments in model systems with computational modeling and database mining of
sequence data to study the constraints on the evolution of resistance, focusing on two key areas: the role of spatial
structure in the evolution of resistance, and the role of selfish genetic elements including phages and parasitic
plasmids. Resistance provides an almost ideal model system for the study of microbial evolution; fitness can be
well defined, imposed selective pressures can be readily tuned, and can emerge either spontaneously or by
horizontal gene transfer. We expect to uncover the evolutionary mechanisms behind the emergence, spread, and
limitation of antibiotic resistance.
当细菌的突变导致a的先前抑制浓度时,抗生素耐药性就出现了
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Baym其他文献
Michael Baym的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Baym', 18)}}的其他基金
相似海外基金
Can antibiotics disrupt biogeochemical nitrogen cycling in the coastal ocean?
抗生素会破坏沿海海洋的生物地球化学氮循环吗?
- 批准号:
2902098 - 财政年份:2024
- 资助金额:
$ 41.87万 - 项目类别:
Studentship
The role of RNA repair in bacterial responses to translation-inhibiting antibiotics
RNA修复在细菌对翻译抑制抗生素的反应中的作用
- 批准号:
BB/Y004035/1 - 财政年份:2024
- 资助金额:
$ 41.87万 - 项目类别:
Research Grant
Metallo-Peptides: Arming Cyclic Peptide Antibiotics with New Weapons to Combat Antimicrobial Resistance
金属肽:用新武器武装环肽抗生素以对抗抗菌素耐药性
- 批准号:
EP/Z533026/1 - 财政年份:2024
- 资助金额:
$ 41.87万 - 项目类别:
Research Grant
Towards the sustainable discovery and development of new antibiotics
迈向新抗生素的可持续发现和开发
- 批准号:
FT230100468 - 财政年份:2024
- 资助金额:
$ 41.87万 - 项目类别:
ARC Future Fellowships
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
- 批准号:
EP/Y023528/1 - 财政年份:2024
- 资助金额:
$ 41.87万 - 项目类别:
Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
- 批准号:
BB/Y007611/1 - 财政年份:2024
- 资助金额:
$ 41.87万 - 项目类别:
Research Grant
The disulfide bond as a chemical tool in cyclic peptide antibiotics: engineering disulfide polymyxins and murepavadin
二硫键作为环肽抗生素的化学工具:工程化二硫多粘菌素和 murepavadin
- 批准号:
MR/Y033809/1 - 财政年份:2024
- 资助金额:
$ 41.87万 - 项目类别:
Research Grant
Role of phenotypic heterogeneity in mycobacterial persistence to antibiotics: Prospects for more effective treatment regimens
表型异质性在分枝杆菌对抗生素持久性中的作用:更有效治疗方案的前景
- 批准号:
494853 - 财政年份:2023
- 资助金额:
$ 41.87万 - 项目类别:
Operating Grants
Imbalance between cell biomass production and envelope biosynthesis underpins the bactericidal activity of cell wall -targeting antibiotics
细胞生物量产生和包膜生物合成之间的不平衡是细胞壁靶向抗生素杀菌活性的基础
- 批准号:
2884862 - 财政年份:2023
- 资助金额:
$ 41.87万 - 项目类别:
Studentship
Narrow spectrum antibiotics for the prevention and treatment of soft-rot plant disease
防治植物软腐病的窄谱抗生素
- 批准号:
2904356 - 财政年份:2023
- 资助金额:
$ 41.87万 - 项目类别:
Studentship